ACCESSION: MSBNK-SMB_Measured-HSA001P0114020
RECORD_TITLE: Annotated; Creatinine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 101
COMMENT: RAW_SPEC {'17_posi_2584': {'bp': 35144436.0, 'sum': 41568773.0}, '8_posi_2311': {'bp': 9162385.0, 'sum': 13606541.0}, '10_posi_2335': {'bp': 11216124.0, 'sum': 16052170.0}, '11_posi_2437': {'bp': 17068124.0, 'sum': 22099939.0}, '17_posi_2521': {'bp': 26180976.0, 'sum': 32073292.0}, '10_posi_2521': {'bp': 27598126.0, 'sum': 33571134.0}, '16_posi_2563': {'bp': 30959254.0, 'sum': 37135698.0}, '17_posi_2333': {'bp': 5582046.0, 'sum': 9568679.0}, '13_posi_2332': {'bp': 7615134.0, 'sum': 12091823.0}, '10_posi_2584': {'bp': 9578088.0, 'sum': 12884913.0}, '16_posi_2374': {'bp': 19530500.0, 'sum': 25269223.0}, '8_posi_2563': {'bp': 20831584.0, 'sum': 25479877.0}, '11_posi_2311': {'bp': 5947328.0, 'sum': 10141030.0}, '15_posi_2605': {'bp': 10436256.0, 'sum': 13917671.0}, '14_posi_2584': {'bp': 13133178.0, 'sum': 16599877.0}, '11_posi_2563': {'bp': 18066042.0, 'sum': 22502666.0}, '10_posi_2458': {'bp': 19149524.0, 'sum': 24401798.0}, '19_posi_2752': {'bp': 4377324.0, 'sum': 6387240.0}, '12_posi_2563': {'bp': 21446360.0, 'sum': 26280436.0}, '4_posi_2500': {'bp': 31575696.0, 'sum': 37770513.0}, '9_posi_2584': {'bp': 12720249.0, 'sum': 16230520.0}, '5_posi_2542': {'bp': 18891722.0, 'sum': 23055876.0}, '3_posi_2521': {'bp': 24916896.0, 'sum': 30391085.0}, '19_posi_2626': {'bp': 26010310.0, 'sum': 31343878.0}, '9_posi_2332': {'bp': 10048583.0, 'sum': 14717799.0}, '5_posi_2479': {'bp': 30256632.0, 'sum': 36297226.0}, '8_posi_2626': {'bp': 2258664.0, 'sum': 4350493.0}, '1_posi_2290': {'bp': 10529427.0, 'sum': 14874356.0}, '7_posi_2332': {'bp': 7995378.0, 'sum': 12571947.0}, '12_posi_2311': {'bp': 7745770.0, 'sum': 11992793.0}, '16_posi_2311': {'bp': 7540097.0, 'sum': 12134984.0}, '4_posi_2311': {'bp': 6180110.0, 'sum': 10347089.0}, '3_posi_2272': {'bp': 4648574.0, 'sum': 8951604.0}, '1_posi_2227': {'bp': 3846254.0, 'sum': 7452536.0}, '14_posi_2521': {'bp': 29596582.0, 'sum': 35577801.0}, '11_posi_2500': {'bp': 24467200.0, 'sum': 30184802.0}, '18_posi_2584': {'bp': 23358604.0, 'sum': 28837328.0}, '18_posi_2647': {'bp': 18789496.0, 'sum': 23070238.0}, '15_posi_2479': {'bp': 16891006.0, 'sum': 21891045.0}, '3_posi_2332': {'bp': 16416877.0, 'sum': 21897665.0}, '17_posi_2647': {'bp': 5437754.0, 'sum': 7320561.0}, '1_posi_2542': {'bp': 4997688.0, 'sum': 7489822.0}, '3_posi_2584': {'bp': 3211309.0, 'sum': 5674333.0}, '12_posi_2627': {'bp': 2260788.0, 'sum': 4279381.0}, '12_posi_2500': {'bp': 25691440.0, 'sum': 31400140.0}, '19_posi_2563': {'bp': 24921844.0, 'sum': 30856670.0}, '1_posi_2479': {'bp': 24433386.0, 'sum': 29829005.0}, '15_posi_2542': {'bp': 21581994.0, 'sum': 26719457.0}, '12_posi_2437': {'bp': 20165858.0, 'sum': 25710339.0}, '3_posi_2395': {'bp': 20164952.0, 'sum': 25937208.0}, '15_posi_2353': {'bp': 8001715.0, 'sum': 12077313.0}, '8_posi_2500': {'bp': 32899348.0, 'sum': 39487625.0}, '9_posi_2521': {'bp': 30030526.0, 'sum': 36200755.0}, '16_posi_2437': {'bp': 21652766.0, 'sum': 27240130.0}, '6_posi_2563': {'bp': 20041522.0, 'sum': 24675525.0}, '8_posi_2374': {'bp': 19819452.0, 'sum': 25215593.0}, '7_posi_2521': {'bp': 18858788.0, 'sum': 23583977.0}, '14_posi_2332': {'bp': 17346326.0, 'sum': 23093179.0}, '1_posi_2416': {'bp': 16334275.0, 'sum': 21339207.0}, '18_posi_2397': {'bp': 4672534.0, 'sum': 8616203.0}, '16_posi_2500': {'bp': 26027458.0, 'sum': 32099772.0}, '10_posi_2395': {'bp': 17408664.0, 'sum': 22670473.0}, '18_posi_2458': {'bp': 14541329.0, 'sum': 19509628.0}, '1_posi_2353': {'bp': 14148332.0, 'sum': 19047168.0}, '13_posi_2458': {'bp': 13250687.0, 'sum': 17848813.0}, '2_posi_2521': {'bp': 12167546.0, 'sum': 16077542.0}, '13_posi_2395': {'bp': 12082528.0, 'sum': 16851155.0}, '7_posi_2584': {'bp': 2509302.0, 'sum': 4817281.0}, '8_posi_2437': {'bp': 24705276.0, 'sum': 30690687.0}, '2_posi_2395': {'bp': 18853474.0, 'sum': 24499719.0}, '17_posi_2395': {'bp': 18723088.0, 'sum': 24448942.0}, '11_posi_2374': {'bp': 16458722.0, 'sum': 21791647.0}, '15_posi_2416': {'bp': 16244905.0, 'sum': 21502648.0}, '14_posi_2269': {'bp': 6122104.0, 'sum': 10256487.0}, '3_posi_2458': {'bp': 26075934.0, 'sum': 32150117.0}, '14_posi_2458': {'bp': 23144542.0, 'sum': 29111306.0}, '4_posi_2437': {'bp': 22379930.0, 'sum': 27858832.0}, '4_posi_2374': {'bp': 21008866.0, 'sum': 26925330.0}, '6_posi_2374': {'bp': 10974497.0, 'sum': 15649778.0}, '2_posi_2269': {'bp': 6849772.0, 'sum': 11212862.0}, '19_posi_2689': {'bp': 33650972.0, 'sum': 39495587.0}, '2_posi_2458': {'bp': 24905930.0, 'sum': 30841985.0}, '9_posi_2395': {'bp': 22971146.0, 'sum': 29291083.0}, '6_posi_2437': {'bp': 21586950.0, 'sum': 27199663.0}, '18_posi_2521': {'bp': 17236828.0, 'sum': 22446422.0}, '13_posi_2584': {'bp': 10587077.0, 'sum': 14462850.0}, '16_posi_2626': {'bp': 4824286.0, 'sum': 6689578.0}, '5_posi_2416': {'bp': 26947614.0, 'sum': 33306159.0}, '5_posi_2353': {'bp': 25930006.0, 'sum': 32406660.0}, '17_posi_2458': {'bp': 25876716.0, 'sum': 32445531.0}, '13_posi_2521': {'bp': 17540612.0, 'sum': 22526873.0}, '7_posi_2458': {'bp': 14977219.0, 'sum': 19512623.0}, '5_posi_2290': {'bp': 13509012.0, 'sum': 18241392.0}, '5_posi_2230': {'bp': 4494418.0, 'sum': 8242930.0}, '6_posi_2500': {'bp': 27565132.0, 'sum': 33392264.0}, '9_posi_2458': {'bp': 26913260.0, 'sum': 33583979.0}, '19_posi_2500': {'bp': 14694106.0, 'sum': 19811372.0}, '7_posi_2395': {'bp': 13942330.0, 'sum': 19044224.0}, '14_posi_2395': {'bp': 24746958.0, 'sum': 31192948.0}, '12_posi_2374': {'bp': 18681942.0, 'sum': 24166403.0}, '2_posi_2332': {'bp': 15397313.0, 'sum': 20467924.0}}
COMMENT: RETENTION_TIME_STDEV 0.222
COMMENT: PRECURSOR_M/Z_RAW 114.066246
COMMENT: PRECURSOR_M/Z_STDEV 0.000032
COMMENT: PRECURSOR_IN_MS1 mz 114.066231; int 999.000; delta(ppm) 1.463779
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+Na; mz 136.048150; int 1.058; cor 0.828
COMMENT: PROPOSED_ION_FORM M+Na; M+2Na-H; mz 136.048150; int 1.058; cor 0.828
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.345; C4H7N3O; [M+H]+; delta(ppm) 0.344953
COMMENT: PROPOSED_MF MS-FINDER 3.556; C4H7N3O; [M+H]+; delta(ppm) 0.339282
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.166; C4H7N3O; [M+H]+; delta(ppm) 0.339282
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.339282
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.556; C4H7N3O; [M+H]+; delta(ppm) 0.339282
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.015; C6H9O2; [M+H]+; delta(ppm) -11.431500
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.448; C4H11O2; [M+Na]+; delta(ppm) 85534.176686
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.027; C2H5N6; [M+H]+; delta(ppm) 12.110341
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H11O2; [M+Na]+; delta(ppm) 85534.176686
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H7N3O; [M+H]+; delta(ppm) 0.339282
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 37.000; DDRJAANPRJIHGJ-UHFFFAOYSA-N; C4H7N3O; CREATININE
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.661; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; CN1C=C(O)N=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.619; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; CN1CC(=O)NC1=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.222; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; CN(CCC#N)N=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; C1C=CNN1C(=O)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.984; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.310; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.284; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.191; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; Creatinine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; BTXYOFGSUFEOLA-UHFFFAOYSA-N; [M+H]+; 2-amino-1-methyl-imidazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.803; PPVUWDCETZMPLT-UHFFFAOYSA-N; [M+H]+; 1,3-dihydropyrazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.115; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; 3-(N-Nitrosomethylamino)propionitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.798; DDRJAANPRJIHGJ-UHFFFAOYSA-N; [M+H]+; 2-amino-3-methyl-4H-imidazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; XGKOIOPVLYCTRF-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; YGVFIVSNVVUSCS-UHFFFAOYSA-N; [M+H]+; 5-amino-2-methyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.916; FOOFYKFJNMAAQE-UHFFFAOYSA-N; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; IRPLFUJJHBGEAL-UHFFFAOYSA-N; [M+H]+; 3-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; AUZHYHBJZVEQNI-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; MKSFCAQPDWJPND-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; BVNFZLFQKJYVDJ-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; XJUQLFVCCWNFJJ-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; LFSXUCZAZSQBPW-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; HUSLEZCKWCUICB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.845; VUYWQWFWWHLKFG-UHFFFAOYSA-N; [M+H]+; 4-amino-5-methyl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.839; NZORXPUYHVZTQG-UHFFFAOYSA-N; [M+H]+; (3-amino-1H-pyrazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; HJEVQOSZWIDFQJ-UHFFFAOYSA-N; [M+H]+; 2-(2H-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.801; PKHVUMMJMYKRNO-UHFFFAOYSA-N; [M+H]+; 2-(triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; CLVALLQETQTQMV-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; DLLDJWMWMVUIDZ-UHFFFAOYSA-N; [M+H]+; (3-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; QUAQZVSGXQVIEP-UHFFFAOYSA-N; [M+H]+; (2-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; KNIARYZRPMJYFH-UHFFFAOYSA-N; [M+H]+; 2-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; WYZRLXYOIMXEBO-UHFFFAOYSA-N; [M+H]+; 1-(1H-1,2,4-triazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.794; XKKMMJLWDOKNEW-UHFFFAOYSA-N; [M+H]+; (1-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; RTCYUGLJCAPLPD-UHFFFAOYSA-N; [M+H]+; (2-methyltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; CIFUFRVSHZKBEO-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; YOSYLAYVXLOORB-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-triazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; WEDYTSQNYJKOPC-UHFFFAOYSA-N; [M+H]+; (1-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.664; HZDLDFBKYBGNHG-UHFFFAOYSA-N; [M+H]+; N-(2-cyanoethyl)-N-methylnitrous amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.341; GZDJNVITGJORKZ-UHFFFAOYSA-N; [M+H]+; ethyl N'-cyanocarbamimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.338; OMFADAFZDYXVOK-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.338; XHSTYRIUVMKGDX-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.323; MTHUPGKUEISSDE-UHFFFAOYSA-N; [M+H]+; 2-amino-N-(cyanomethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.301; KXLLKSHFFVQKTQ-UHFFFAOYSA-N; [M+H]+; 2-cyanoethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.300; HGPUJQWMCPURNO-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.299; LODVFGWSULLZAU-UHFFFAOYSA-N; [M+H]+; 4-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.290; OTERRMWTPZGJLB-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.288; HKIXGXYGOILGSX-UHFFFAOYSA-N; [M+H]+; 2-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.288; YUTNQQHHUYYBFA-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.288; CIHQZPVUYBHNQO-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.280; PFBCKBGKRFYNLE-UHFFFAOYSA-N; [M+H]+; (5-methyl-2H-triazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.274; HNXYWYOVPHLAQF-UHFFFAOYSA-N; [M+H]+; N,4-dimethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.273; YKTPXKSUWIQBML-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2,5-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.272; NPBUMVMXXGQOEG-UHFFFAOYSA-N; [M+H]+; (3-methyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.271; KPBSGOLXLCARIL-UHFFFAOYSA-N; [M+H]+; (5-methyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.270; BMTFHVKZYIOHBE-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.256; YWXPPKJKSSLZOD-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.252; DSFUCCQCXNNWLA-UHFFFAOYSA-N; [M+H]+; 3-methoxy-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.133; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.937; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.007; OTERRMWTPZGJLB; [M+H]+; 4-ethyl-1,2,5-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.615; OMFADAFZDYXVOK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.605; HGPUJQWMCPURNO; [M+H]+; Ambcb4035725
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.162; RTCYUGLJCAPLPD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.310; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.604; XHSTYRIUVMKGDX; [M+H]+; 2-NH2-5-ET-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.309; DLLDJWMWMVUIDZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.291; HZDLDFBKYBGNHG; [M+H]+; 3-Methylnitrosaminopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.761; IRPLFUJJHBGEAL; [M+H]+; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.977; CLVALLQETQTQMV; [M+H]+; triazolylethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.988; MKSFCAQPDWJPND; [M+H]+; Azamuscimol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.354; PKHVUMMJMYKRNO; [M+H]+; 2-(1-triazolyl)ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.244; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -23.558; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -111.362; XGKOIOPVLYCTRF; [M+H]+; 3-amino-1-methyl-4,5-dihydro-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.915; PPVUWDCETZMPLT; [M+H]+; 5-Dihydro-1h-pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -141.705; HZDLDFBKYBGNHG; [M+H]+; 3-(Methyl-D3-nitrosoamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.515; KXLLKSHFFVQKTQ; [M+H]+; 2-Cyanoethylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -145.483; CMIPWACBRYWGPN; [M+H]+; 1-Cyano-2,3-dimethylisourea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -163.972; IRPLFUJJHBGEAL; [M+H]+; 5-amino-1-methyl-1H-pyrazol-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.038; FOOFYKFJNMAAQE; [M+H]+; N-ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.999; XHSTYRIUVMKGDX; [M+H]+; 5-Ethyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.800; BVNFZLFQKJYVDJ; [M+H]+; 3H-1,2,4-Triazol-3-one, 2,4-dihydro-4,5-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.901; DDRJAANPRJIHGJ; [M+H]+; Kreatinin
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Creatinine, DDRJAANPRJIHGJ-UHFFFAOYSA-N; Matching to 37 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000562;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C4H7N3O
CH$EXACT_MASS: 113.058912
CH$SMILES: CN1CC(=O)N=C1N
CH$IUPAC: InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)
CH$LINK: CHEBI CHEBI:16737
CH$LINK: HMDB HMDB0000562
CH$NAME: Creatinine
CH$NAME: Creatinine
CH$NAME: 2-amino-3-methyl-4H-imidazol-5-one
CH$LINK: INCHIKEY DDRJAANPRJIHGJ-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:588
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.926
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 114.066227
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-1900000000-3180f6727c487bc6bfbc
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  71.0603668 120.1048 71.060980 0.2533 89.97 -0.0410 101 f{C3H7N2}/-0.11ppm,p-C1H1N1O1
  72.0443735 7.6262 72.044980 0.4581 0.65 0.9891 101 f{C3H6N1O1}/-0.23ppm,p-C1H2N2
  85.0760508 1.0945 85.076530 1.4105 0.66 0.4724 71 ?
  86.0712535 85.6294 86.071720 0.2556 5.06 0.9974 101 f{C3H8N3}/-0.23ppm,p-C1O1
  104.0818341 15.4665 104.082120 0.3939 4.62 0.9013 101 ?
  114.0662277 999.0000 114.066410 0.3682 0.00 1.0000 101 f{C4H8N3O1}/0.35ppm,p
  114.1020581 108.9721 114.102240 1.4987 82.60 -0.0553 101 ?
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  71.060367 120.10 120
  72.044373 7.63 7
  85.076051 1.09 1
  86.071253 85.63 85
  104.081834 15.47 15
  114.066228 999.00 999
  114.102058 108.97 108
//
